Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 131 results for "harvard bone marrow initiative"

Axsome Therapeutics Initiates Phase 3 Study of AXS-05 for Trea...

First Patient Enrolled in the STRIDE-1 Study Second Product Candidate Axsome Has Advanced into a Pivotal Trial NEW YORK, March 17, 2016 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company ... 4 Traders, 2 months ago
Physicians Weekly

Antiretroviral Therapy: Not Enough for HIV-Associated Arterial Inflammation?

Additional immune-system-modulatory approaches may help reduce risk of cardiovascular disease. Initiating antiretroviral therapy (ART) soon after diagnosis of an HIV infection did not prevent the progression of significant arterial inflammation in ...
 PharmaceuticalProcessing14 hours ago ART alone not sufficient to reduce arterial inflammation among HIV-infected patients, study finds  News-Medical.Net19 hours ago Antiretroviral therapy may not be enough to reduce HIV-associated arterial inflammation  Biocompare1 day ago

The Cancer Industry Exposed In Less Than 2000 Words

(Before It's News)An Exclusive You Have To See: Facebook's Diabolical New Initiative Is Causing Mass Exodus—1000s Shut Down As They Discover… by Arjun Walia, Collective Evolution It's hard to believe that approximately one in every two people ...
 Before It's News1 month ago

Full Show: Preventing Myeloma Before it Gets Started with Dr. Irene Ghobrial, MD, Dana Farber Cancer Institue

Dr. Irene Ghobrial, MD Dana Farber Cancer Institute / Harvard School of Medicine Interview Date: March 17, 2016 Summary Can we prevent smoldering myeloma or MGUS from progressing to active myeloma? Dr. Irene Ghobrial, MD wonders why we are ...
 Myeloma Crowd1 month ago Full Show: Achieving Minimal Residual Disease with Myeloma Vaccines with Dr. David Avigan, MD Beth Israel Deaconess Medical Center  Myeloma Crowd2 months ago

Biostage Launches Stock Offering To Fund Clinical Trials

Photo from Biostage's LinkedIn page The tissue regeneration company is preparing for human testing. by Don Jacobson May 25, 2016 It's full speed ahead for a collaboration between the Mayo Clinic and regenerative medicine startup Biostage ...
 Twin Cities Business1 day ago

Debate: No One-Size-Fits-All in Multiple Myeloma

NEW YORK—Multiple myeloma survival is improving dramatically with the introduction of novel therapeutic agents and combination approaches, but no one therapy or modality fits all patients, according to two myeloma experts who squared off in a ...
 Oncology Times6 days ago Novel Agent BION-1301 May Block Multiple Myeloma Cell Proliferation  Targeted Oncology2 weeks ago Aduro Biotech Reports Publishing of Key Preclinical Data Highlighting New Approach to Treat Multiple Myeloma  Morningstar.com4 weeks ago Aduro Biotech Announces Key Preclinical Data Published Highlighting New Approach to Treat Multiple Myeloma  4 Traders4 weeks ago

Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral

By a News Reporter-Staff News Editor at Pharma Business Week -- Amgen (NASDAQ: AMGN) and LabCentral announced that Platelet BioGenesis is an Amgen's 2016 winner of the highly competitive Golden Ticket award, which underwrites the cost of a lab bench ...
 4 Traders1 week ago AMGEN : Platelet BioGenesis Wins Amgen Golden Ticket For LabCentral  4 Traders2 weeks ago

Editas Medicine's (EDIT) CEO Katrine Bosley on Q1 2016 Results - Earnings Call Transcript

Editas Medicine, Inc. (NASDAQ: EDIT ) Q1 2016 Results Earnings Conference Call May 16, 2016 08:30 AM ET Executives Mark Mullikin - Senior Director, Finance and IR Katrine Bosley - CEO Andrew Hack - CFO Alexandra Glucksmann - COO ...
 Seeking Alpha1 week ago Mesoblast's (MEOBF) CEO Silviu Itescu on Q3 2016 Results - Earnings Call Transcript  Seeking Alpha2 weeks ago

List of Dead Microbiologists

The worlds top anti-virus microbiologists are being killed off. By 2005, 40 were dead. Today, over 100. Many murdered, the rest died under very suspicious circumstances. It is known they were all working on highly sensitive or government-funded ...
 Before It's News2 weeks ago

Identifying drug targets for leukaemia

Researchers from Hong Kong and the U.S. have developed a new statistical and mapping method that could help identify drug targets for treating leukaemia. In chronic myelogenous leukaemia (CML), too many stem cells in the bone marrow are ...
 Innovations Report3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - harvard bone marrow initiative
Get updated on latest news & your favorite topics right in your inbox!
More     Less